Elevated levels of type I IFN, a key regulator of the innate immune system, have been reported in SSc patients [12–14], and IFN-regulated genes have been shown to contribute to the prediction of skin fibrosis worsening [39]. This evidence concerns the gene IFNA1 and systemic sclerosis.